Selected Publication:
SHR
Neuro
Cancer
Cardio
Lipid
Metab
Microb
Wiedemann, D; Bernardi, MH; Distelmaier, K; Goliasch, G; Hengstenberg, C; Hermann, A; Holzer, M; Hoetzenecker, K; Klepetko, W; Lang, G; Lassnigg, A; Laufer, G; Magnet, IAM; Markstaller, K; Röggla, M; Rössler, B; Schellongowski, P; Simon, P; Tschernko, E; Ullrich, R; Zimpfer, D; Staudinger, T, , COVID-19, ECMO, Arbeitsgruppe, Medizinische, Universität, Wien.
[Recommendations for Extracorporeal Membrane Oxygenation (ECMO) in COVID-19 Patients].
Wien Klin Mag. 2020; 23(4):168-173
Doi: 10.1007/s00740-020-00349-x
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
- Co-authors Med Uni Graz
-
Zimpfer Daniel
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- The pandemic from the SARS-CoV‑2 Virus is currently challenging health care systems all over the world. Maintaining appropriate staffing and resources in healthcare facilities is essential to guarantee a safe work environment for healthcare personnel and safe patient care. Extracorporeal membrane oxygenation (ECMO) represents a valuable therapeutic option in patients with severe heart or lung failure. Although only a limited proportion of COVID-19 patients develops respiratory or circulatory failure that is refractory to conventional therapies, it is of utmost importance to clearly define criteria for the use of ECMOs in this steadily growing patient population. The ECMO working group of the Medical University of Vienna has established the following recommendations for ECMO support in COVID-19 patients.
- Find related publications in this database (Keywords)
-
ECMO
-
COVID-19
-
Extracorporeal life support
-
Pandemic
-
Corona virus